Skip to content
JBSPR- Journal of Basic and Social Pharmacy Research
  • Home
  • Journal Info
    • About Us
    • Editorial Board
    • Contact Us
  • Current Issue
  • Past Editions
    • Volume 1, Issue 1,2019.
    • Volume 1, Issue 2,2019.
    • Volume 1, Issue 3, 2020
    • Volume 1, Issue 4, 2020
    • Volume 1, Issue 5, 2020
    • Volume 2, Issue 1, 2021
    • Volume 2, Issue 2, 2021
    • Volume 2, Issue 3, 2022
    • Volume 2, Issue 4, 2022
    • Volume 2, Issue 5, 2022
    • Volume 2, Issue 6, 2022
    • Volume 3, Issue 1, 2023
  • Special Supplement on COVID-19
  • Author Instructions
    • Instructions to Authors
    • Submission Information
Menu Close

Physicochemical Evaluation of Brands of Amlodipine Besylate Tablets.

Anyanwu-Ndulewe CA
Mogbolu LE
Oladunni MA
Adepoju-Bello AA

https://doi.org/10.52968/27459534

About Us

The Journal of Basic and Social Pharmacy Research (JBSPR) is a quarterly peer-reviewed online publication of the Department of Clinical Pharmacy and Biopharmacy, Faculty of Pharmacy, University of Lagos

Pages

Home
About Us
Current Issue
Special Supplement on COVID -19
Instructions To Authors
Submission Information
Blog
Editorial Board
Contact Us

External Links

University of Lagos
PSN
PSNNJP
WHO
FIP
NIGJPHARMRES

Contact Us

Journal Office,
c/o Department of Clinical Pharmacy and Biopharmacy,
Faculty of Pharmacy, University of Lagos, 
Idiaraba Campus, Idiaraba, 
Lagos, Nigeria.

Emails: info.jbspr@gmail.com
info.jbspr@unilag.edu.ng
Phone Number: +2349010759680

© Journal of Basic and Social Pharmacy Research, 2024.
  • Home
  • Journal Info
    • About Us
    • Editorial Board
    • Contact Us
  • Current Issue
  • Past Editions
    • Volume 1, Issue 1,2019.
    • Volume 1, Issue 2,2019.
    • Volume 1, Issue 3, 2020
    • Volume 1, Issue 4, 2020
    • Volume 1, Issue 5, 2020
    • Volume 2, Issue 1, 2021
    • Volume 2, Issue 2, 2021
    • Volume 2, Issue 3, 2022
    • Volume 2, Issue 4, 2022
    • Volume 2, Issue 5, 2022
    • Volume 2, Issue 6, 2022
    • Volume 3, Issue 1, 2023
  • Special Supplement on COVID-19
  • Author Instructions
    • Instructions to Authors
    • Submission Information